Two of the world’s largest beauty companies are deepening their involvement in the aesthetics sector — not by creating recovery serums or forming partnerships with clinics, but by designing the tools themselves.
In May, Shiseido launched its MicroClick Concentrate in Japan, a sleek, single-use microneedling device priced at ¥36,300 (about $250). This marks Shiseido’s entry into consumer-grade microneedling tools. The device features a disposable array of 18 micro-needles designed to deliver niacinamide and barrier-repairing ingredients deep into the skin. Beyond just acting as a delivery system, Shiseido claims the device also stimulates blood flow and boosts gene expression related to collagen production and immunity.
Meanwhile, L’Oréal is gearing up to launch the Lancôme 400 Booster in the U.K. this September, through retailer Boots. Priced at £250 (approximately $340), this high-end microneedling tool uses 400 nano-needles and was co-developed with the Chinese semiconductor firm Suzhou Nanosheng Electronics. Backed by clinical studies published in the International Journal of Cosmetic Science, the Lancôme 400 Booster creates “invisible micro-channels” to enhance the absorption of active ingredients without causing downtime. This feature is particularly appealing to today’s beauty consumers who prefer convenience without compromising on results.
Both products represent a significant shift in the beauty industry’s approach. Rather than remaining in the background, these brands are stepping into the role of developing medical-grade devices for home use, catering to consumers who are increasingly seeking professional-level treatments from the comfort of their own homes.
Related topics:
